Increased cardiovascular risk in CABG patients might increase the expression of NLRP3 inflammasome markers, since those patients often presented hypertension, diabetes and obesity, which have been associated with NLRP3 inflammasome activation. The gene discussed is NLRP3; the disease is obesity due to melanocortin 4 receptor deficiency.